Price control not the best way to achieve affordability: NPPA Chairman Bhupendra Singh

While the National Pharmaceutical Pricing Authority (NPPA) revised the ceiling price on coronary stents on Monday, its Chairman Bhupendra Singh stated on Friday that that the price control is not the best option to achieve affordability. “If you ask me, I don’t consider that price control is the best option to achieve affordability.